Genscript Biotech Corp (1548):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genscript Biotech Corp (1548) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8160
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genscript Biotech Corp (Genscript Biotech) is a biotechnology company that provides life sciences research and application services and products. The company offers wide range of services in peptide synthesis, gene synthesis, protein expression and engineering, molecular biology, custom antibody development and engineering, animal model development, and in vitro and in vivo pharmacology. Its product portfolio comprises antibodies, recombinant proteins, stable cell lines, molecular biology reagents, peptides and biochemicals, CRISPR Cas9 reagents and others. The company’s products and services find application in life science research, vaccine development, immunotherapy, and drug discovery and development. It has presence in the US, China and Japan. Genscript Biotech is headquartered in Nanjing, Jiangsu, China.

Genscript Biotech Corp (1548) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genscript Biotech Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genscript Biotech Corp, Medical Devices Deals, 2012 to YTD 2018 9
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genscript Biotech and Harbin Gloria Pharma Enter into Development Agreement 11
Licensing Agreements 12
Bliss Biopharma Enters into Licensing Agreement with Genscript Biotech 12
Janssen Biotech Enters into Licensing Agreement with Legend Biotech 13
Equity Offering 14
Genscript Biotech to Raise Funds through Private Placement of Shares 14
Genscript Biotech Completes Underwriters Exercise of Over-Allotment Option of IPO for USD77.7 Million 15
Acquisition 17
Genscript Biotech Acquires Customarray 17
Genscript Biotech Corp – Key Competitors 18
Genscript Biotech Corp – Key Employees 19
Genscript Biotech Corp – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 27, 2018: Genscript Biotech: Announcement of unaudited consolidated interim results for the six months ended June 30, 2018 21
Aug 28, 2017: Genscript Biotech: Announcement Of Unaudited Consolidated Interim Results For The Six Months Ended June 30, 2017 22
Mar 20, 2017: Genscript Biotech: Annual Results Announcement For The Year Ended December 31, 2016 25
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genscript Biotech Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genscript Biotech Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Genscript Biotech Corp, Medical Devices Deals, 2012 to YTD 2018 9
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genscript Biotech and Harbin Gloria Pharma Enter into Development Agreement 11
Bliss Biopharma Enters into Licensing Agreement with Genscript Biotech 12
Janssen Biotech Enters into Licensing Agreement with Legend Biotech 13
Genscript Biotech to Raise Funds through Private Placement of Shares 14
Genscript Biotech Completes Underwriters Exercise of Over-Allotment Option of IPO for USD77.7 Million 15
Genscript Biotech Acquires Customarray 17
Genscript Biotech Corp, Key Competitors 18
Genscript Biotech Corp, Key Employees 19
Genscript Biotech Corp, Subsidiaries 20

List of Figures
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genscript Biotech Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genscript Biotech Corp (1548):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inovise Medical, Inc.:企業の戦略的SWOT分析
    Inovise Medical, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Rose Petroleum plc (ROSE):企業の財務・戦略的SWOT分析
    Summary Rose Petroleum Plc (Rose Petroleum), formerly Vane Minerals plc is an oil and gas company. The company explores and produce oil and gas, silver, gold, copper, and uranium deposits across the US and Mexico. Its oil and gas project is located in Paradox Basin in Utah, the US, which covers over …
  • Veniti Inc:医療機器:M&Aディール及び事業提携情報
    Summary Veniti Inc (Veniti) is a medical device company that develops venous system management solutions. The company manufactures, develops, and markets medical devices for the treatment of chronic venous diseases. It offers VICI venous stent system that is used to treat venous outflow obstruction …
  • Acacia Research Corp:企業のM&A・事業提携・投資動向
    Acacia Research Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acacia Research Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Miltenyi Biotec GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulati …
  • BioRestorative Therapies Inc (BRTX)-医療機器分野:企業M&A・提携分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Phoenix Beverages Limited:戦略・SWOT・企業財務分析
    Phoenix Beverages Limited - Strategy, SWOT and Corporate Finance Report Summary Phoenix Beverages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lario Oil & Gas Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Lario Oil & Gas Co (Lario Oil & Gas) is an oil and gas exploration and production company that explores and produces oil and gas properties. The company offers services such as discovering reserves organically from geologic thesis, drill-bit, field delineation, and land acquisition and explo …
  • Oncgnostics GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that offers development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline products include GynTect technology a system based on the detection of epigenetic biomarkers mainly in the methyla …
  • Prairie Land Electric Cooperative Inc:企業の戦略的SWOT分析
    Prairie Land Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • Bayshore Petroleum Corp (BSH):石油・ガス:M&Aディール及び事業提携情報
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. Its CCC technology provides heavy oil and …
  • Essilor International S.A.:企業の戦略・SWOT・財務情報
    Essilor International S.A. - Strategy, SWOT and Corporate Finance Report Summary Essilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Buckeye Partners LP (BPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Buckeye Partners LP (Buckeye) is a provider of midstream logistic solutions. It owns and operates a diversified network of integrated assets for the transportation, storage, processing and marketing of liquid petroleum products. The company transports liquid petroleum products, including gas …
  • Orbit International Corp.:戦略・SWOT・企業財務分析
    Orbit International Corp. - Strategy, SWOT and Corporate Finance Report Summary Orbit International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Flowonix Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Flowonix Medical Inc (Flowonix), formerly Medasys Inc is a medical device company that designs and manufactures implantable drug pump to deliver therapeutic drugs into the spine to relieve chronic disorders. The company's products include prometra pump, catheter, and accessories and programm …
  • American Axle & Manufacturing Holdings, Inc.:企業の戦略・SWOT・財務分析
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • CARE Super Pty Ltd:企業の戦略・SWOT・財務分析
    CARE Super Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary CARE Super Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Westell Technologies Inc (WSTL):企業の財務・戦略的SWOT分析
    Summary Westell Technologies Inc (Westell) provides network infrastructure solutions. It provides wireless infrastructure solutions such as in-building wireless, communication network solutions, optima management system, and intelligent site management solutions. The company’s in-building wireless p …
  • Lincoln Pharmaceuticals Ltd (LINCOLN):企業の財務・戦略的SWOT分析
    Lincoln Pharmaceuticals Ltd (LINCOLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆